Where we are
Nicox’s headquarters are located in the South of France in Sophia Antipolis (Nice area). The Group has a research center in Bresso (Milan area, Italy) and a US office (Durham, North Carolina)

1 France

Nicox S.A. Drakkar 2 – Bât D 2405 route des Dolines – CS 10313 Sophia Antipolis – 06560 Valbonne

Tel: +33 (0)4 97 24 53 00

Fax: +33 (0)4 97 24 53 99

2 Italy

Nicox Research Institute Via Ludovico Ariosto, 21 20091 Bresso, Milano

Tel: +39 02 61036 1

Fax: +39 02 61036 430

3 United States

Nicox Ophthalmics, Inc. North Carolina Biotechnology Center 15 TW Alexander Dr, 4th floor Research Triangle Park, NC 27709

T: +1 919 541 93 66

Main subsidiaries
Nicox S.A. is the parent company of the Nicox Group and is based in France. Nicox S.A. has two international subsidiaries, one focused on Development and the other one on Research.

Nicox Research Institute – Italy

The Nicox Research Institute, based in Milan, Italy, is a small team of scientists with a strong expertise in the synthesis and biological testing of nitric oxide (NO)-donating molecules. The group works through collaborations with high-quality contract research organisations and universities throughout the world, and also manages the extensive Nicox patent portfolio.

Nicox Ophthalmics, Inc. – United States

Nicox Ophthalmics, Inc. (previously known as Aciex Therapeutics, Inc.) is Nicox’s therapeutic development subsidiary in the United States. Aciex Therapeutics, Inc. was acquired by Nicox in October 2014 and renamed Nicox Ophthalmics, Inc. in April 2015. This acquisition significantly broadened and strengthened Nicox’s therapeutic pipeline, notably with ZERVIATE for allergic conjunctivitis and NCX 4251 for blepharitis. For more information on the acquisition of Aciex, please see the Nicox press releases dated July 2 and October 27, 2014.

Working with us

As a Nicox employee, you are immediately part of a dynamic and ambitious team operating in a growing healthcare segment. We are looking for passionate talented people who will embrace the experience and challenge of Nicox to become a recognized and successful player in the ophthalmic market. We currently employ around 31 people worldwide and offer a multicultural and exciting working environment with potential for career development along with Company growth.

Job offers

Sorry, no job offers.

Unsolicited application

Please use the contact form if you wish to send us a spontaneous application.